public health
-
FDA Panelists Vote to Ease Restrictions on Avandia
Avandia, also known as rosiglitazone, may get a second chance after a panel of FDA advisers voted 20 to 26 to recommend removing or modifying the drug’s highly restrictive label and distribution system.
Latest Research Articles
-
Scientists Argue Whether Proton Therapies Used to Treat Cancer are Worth the Costs
-
DSM 5 Lists Caffeine Intoxication and Withdrawal as Disorders
-
Sleep-deprived Men More Likely to Perceive Women as More Eager to Have Sex
-
Safe Travels: Majority of In-flight Medical Crises Seen to by Medically-trained Passengers
-
MERS Patients May Require Longer Quarantine: A Report
-
Copper Capable of Destroying Norovirus: A Study
-
Many Medical Students Unaware of Their Bias Toward Obese Patients: A Study
-
Bird Flu May Soon Spread Between Humans (if it Doesn't Already), Health Officials Warn
-
First-Ever Study on Fungal Diversity Finds Feet Are Home to More Than 80 Types of Fungus
-
Overeating Learned in Infancy: A Study
-
Vitamin C May Be the Answer in the Fight Against Tuberculosis
-
Mysterious Disease Infects 7, Kills 2 in Alabama